Cordlife Group Limited
Listed on the Main Board of the Singapore Exchange ("SGX"), Cordlife Group Limited ("Cordlife", and together with its subsidiaries, the "Group") is presently a service provider of umbilical cord blood and cord lining banking. The first cord blood bank to be set up in Singapore (May 2001) and amongst the first in Asia, Cordlife Group Limited has more than 14 years of cord blood banking experience as well as a published track record of cord blood transplants.
The Group currently owns and operates full processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia and The Philippines. Its processing and storage facilities in Singapore, Hong Kong and India are also AABB (formerly known as American Association of Blood Banks) accredited, meeting the gold standard of private cord blood banking. The Group also has a direct investment in China Cord Blood Corporation, one of the top operators in China as well as in Stemlife Berhad, a fully licensed cord blood banking facility with the Ministry of Health Malaysia currently listed on the ACE Market of Bursa Malaysia.
We are a consumer healthcare company that serves the needs of the mother and child. We deliver the highest of quality standards in service and product offerings. We maximise all stakeholders' value by engaging all employees to enable the Company to achieve its fullest potential.
As a company, and as individuals working collectively, we value integrity, honesty, openness, pursuit of excellence, creativity, constructive self-criticism, continuous self-improvement, and mutual respect. We are committed to our clients and partners, and have a passion for innovation. We embrace big challenges and pride ourselves on seeing them through. We hold ourselves accountable to our clients, shareholders, employees and regulators by honouring our commitments, providing results and striving for the highest quality.